*EMBARGOED All research presented at the 2023 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 22, 2023, at 3:00 pm PT.
P1950 – Combined Oral Contraceptives Are Associated With Increased Risks of Developing Irritable Bowel Syndrome
Monday, October 23, 2023 | 10:30 AM – 4:15 PM PT | Location: Exhibit Hall
Author Insight from Yuhan Fu, DO, University of Louisville, Louisville, KY
What’s new here and important for clinicians?
Our study has shown that combined oral contraceptives are associated with increased risks of developing new-onset irritable bowel syndrome (IBS) and its subtypes, including IBS with predominant constipation (IBS-C), IBS with predominant diarrhea (IBS-D), and IBS with mixed bowel habits (IBS-M).
What do patients need to know?
Combined oral contraceptives are associated with higher risks of developing new-onset irritable bowel syndrome in women of reproductive age.
Read the Abstract
Yuhan Fu, DO, University of Louisville, Louisville, KY
yfu002 [at] gmail.com
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.